Immediate Impact
50 standout
Citing Papers
Chitosan immunomodulation: insights into mechanisms of action on immune cells and signaling pathways
2025 Standout
A novel small-molecule PCSK9 inhibitor E28362 ameliorates hyperlipidemia and atherosclerosis
2024 Standout
Works of Shahin Jaffer being referenced
Efficacy and safety of chitosan HEP-40 in the management of hypercholesterolemia: a randomized, multicenter, placebo-controlled trial.
2007
Contemporary Management of Dyslipidemia in High-Risk Patients: Targets Still Not Met
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Shahin Jaffer | 89 | 133 | 32 | 68 | 11 | 243 | |
| Jacqueline Honerlaw | 68 | 103 | 24 | 60 | 19 | 281 | |
| Ashley Galloway | 93 | 110 | 15 | 80 | 11 | 266 | |
| Keld Per Kjeldsen | 171 | 78 | 37 | 61 | 9 | 299 | |
| H Asita de Silva | 123 | 120 | 16 | 35 | 12 | 247 | |
| Lotte Kaasenbrood | 144 | 143 | 15 | 81 | 9 | 299 | |
| Damiano Parretti | 132 | 70 | 18 | 60 | 20 | 271 | |
| D.W. Erkelens | 49 | 146 | 20 | 106 | 12 | 268 | |
| Nina Gotcheva | 191 | 98 | 20 | 47 | 16 | 280 | |
| Carel Bakx | 91 | 110 | 56 | 20 | 13 | 285 | |
| Margarida Borges | 49 | 134 | 24 | 32 | 7 | 262 |
All Works
Login with ORCID to disown or claim papers
Loading papers...